Medtronic, medtech's No. 1 player, did not disappoint the market with its final fiscal quarter performance. With revenue and profit figures exceeding analysts' expectations, the group's outlook for fiscal 2018 is also looking equally positive.
Medtronic PLC saw annual revenue grow 5% to $29.71bn and net income widen to $4.02bn for fiscal 2017, beating market forecasts in what chairman and CEO Omar Ishrak described as "a solid year" for the company.
A strong fourth-quarter helped to bring the fiscal year to a positive end. In Q4, Medtronic posted worldwide sales of $7.91bn, up 5% on a reported and constant currency basis....
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
